Use of PER977 to reverse the anticoagulant effect of edoxaban.

dc.contributor.author	Ansell, Jack E
dc.contributor.author	Bakhru, Sasha H
dc.contributor.author	Laulicht, Bryan E
dc.contributor.author	Steiner, Solomon S
dc.contributor.author	Grosso, Michael
dc.contributor.author	Brown, Karen
dc.contributor.author	Dishy, Victor
dc.contributor.author	Noveck, Robert J
dc.contributor.author	Costin, James C
dc.coverage.spatial	United States
dc.date.accessioned	2015-12-15T16:16:44Z
dc.date.issued	2014-11-27
dc.identifier	http://www.ncbi.nlm.nih.gov/pubmed/25371966
dc.identifier.eissn	1533-4406
dc.identifier.uri	https://hdl.handle.net/10161/11170
dc.language	eng
dc.publisher	Massachusetts Medical Society
dc.relation.ispartof	N Engl J Med
dc.relation.isversionof	10.1056/NEJMc1411800
dc.subject	Arginine
dc.subject	Blood Coagulation
dc.subject	Factor Xa Inhibitors
dc.subject	Heparin Antagonists
dc.subject	Humans
dc.subject	Piperazines
dc.subject	Pyridines
dc.subject	Thiazoles
dc.title	Use of PER977 to reverse the anticoagulant effect of edoxaban.
dc.type	Journal article
pubs.author-url	http://www.ncbi.nlm.nih.gov/pubmed/25371966
pubs.begin-page	2141
pubs.end-page	2142
pubs.issue	22
pubs.organisational-group	Duke
pubs.organisational-group	Staff
pubs.publication-status	Published
pubs.volume	371

Files

Now showing 1 - 1 of 1